Sleep DisturbanceNCT07746011
A Clinical Trial to Evaluate the Effects of EMF Protection Devices on Sleep and Energy Levels
A study testing EMF Protection in people with Sleep Disturbance and Insomnia, run by Life Harmony Energies, Inc. at 1 site in United States.
Trial summary
This study evaluates the effects of a selection of EMF protection devices (Home Harmonizers, Better ZZZs, iCell Chip, Car Harmonizer, Laptop Chip, XL Band, and Device Chips) on sleep quality, sleep quantity, and energy levels in adults aged 30-60 who currently experience sleep difficulties. Read more about this study
- Who is it for?
- Ages 30 to 60 years
- Conditions the study is for
- Sleep Disturbance, Insomnia, Fatigue
- What is being tested?
- EMF Protection
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 24 participants
- Where
- 1 siteUnited States
- Study dates
- 15 Aug 2025to 15 Nov 2025
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 30 to 60 years
- All sexes
- No healthy volunteers
- Adult
Who may be able to join
- Be male or female
- Be aged 30-60
- Anyone currently experiencing issues regarding any of the following: sleeping, falling asleep, staying asleep, or failing to feel refreshed after sleep
- Must have all of the following items: bed with a foam or spring mattress, a car with a single cigarette lighter, iPhone 12, 13, 14, 15, or 16, laptop, and Wi-Fi router
- Must have at least two of the following: Wi-Fi extender, smart TV, personal computer, ceiling fan in the bedroom, air purifier
- Must have access to where the electricity enters the home, such as an electric (smart) meter outside, the pipe closest to the electric meter, or the fuse box inside the home
Show all 15Show fewer
- If taking any products, medications, or supplements that target sleep and/or energy during the test period, has been doing so consistently for three months, and is willing to maintain this routine for the duration of the study
- Willing to maintain their current diet, sleep schedule, and activity level for the duration of the study
- Must be able to sleep at home consistently and must not plan to travel for business, vacation, or any other reason during the study period
- Anyone who lives in a single-family residence (i.e., no apartments, condos, or mobile homes)
- Willing to stop using a cellphone watch for the duration of the study
- Must be willing to wear a wristband all day, shaped much like a cellphone watch, and to remove it at night while sleeping
- Willing to remove any other fitness tracking or sleep tracking devices during the study, such as Fitbits, Garmin, and Whoop products
- Must be willing to wear an Oura Ring 24 hours per day during the duration of the study
- Resides in the United States
Who cannot join
- Anyone with pre-existing chronic conditions that would prevent participants from adhering to the protocol, such as cancer, auto-immune conditions, mental health disorders, history of serious illness in the last three months, history of substance abuse, or planned surgery during the study period
- Sleeps on any of the following beds: adjustable beds, beds equipped with grounding mats, or any bed that connects to an electrical outlet
- Anyone with a sleep-related condition or disorder
- Anyone who is pregnant, breastfeeding, or trying to conceive (or who will be at any point during the study period)
- Anyone who drinks heavily (i.e., 8 or more alcoholic drinks per week for women or 15 or more alcoholic drinks per week for men)
- Anyone who lives within 50 miles of a military base or one block of XL powerlines or a cell tower
Show all 10Show fewer
- Anyone who lives in a rural/country home
- Anyone unwilling to follow the study protocol
- Currently partaking in another research study and will not be partaking in any other research study for the next four weeks or at any point during this study's duration
- Anyone who has Starlink internet or fiber-optic internet
Trial locations and contacts
1 site in 1 country.
About this study
This study evaluates the effects of a selection of EMF protection devices (Home Harmonizers, Better ZZZs, iCell Chip, Car Harmonizer, Laptop Chip, XL Band, and Device Chips) on sleep quality, sleep quantity, and energy levels in adults aged 30-60 who currently experience sleep difficulties. The trial is a single-arm, unblinded, virtual study conducted over 4 weeks and 4 days (including a 4-day calibration period).
Twenty-four participants will use all test products daily and complete self-reported questionnaires at Baseline, Day 2, Day 4, Week 1, Week 2, Week 3, and Week 4. Objective sleep data will be collected via an Oura Generation 3 ring worn throughout the study. Secondary outcomes include participants' perceptions of effects on sleep, energy, focus, and general well-being.
- Conditions
- Sleep Disturbance, Insomnia, Fatigue, Electromagnetic Field Exposure
- Being tested
- EMF Protection
- Medical subject headings
- Parasomnias, Sleep Initiation and Maintenance Disorders, Fatigue
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
EMF ProtectionDevice
All participants receive and use all test products simultaneously: 2 Home Harmonizers, 1 Better ZZZs pad (placed under mattress), 1 iCell Chip (for iPhone 12-16), 1 Car Harmonizer (inserted into car cigarette lighter), 1 Laptop Chip, 1 XL Band (worn on wrist during waking hours), and 8 Device Chips (placed on household EMF-emitting devices).
| Study group | Role | What they receive |
|---|---|---|
| EMF Protection Devices | Experimental | Not described Receives: Device: EMF Protection |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in objective sleep quality
Assessed using Oura Generation 3 ring sleep metrics. Change from baseline will be evaluated at each subsequent assessment.
Measured: Baseline, Day 2, Day 4, Week 1, Week 2, Week 3, and Week 4
Secondary outcomes (5)
Change in Self-Reported Sleep
Assessed using validated sleep questionnaire total score(s). Change from baseline will be evaluated at each subsequent assessment.
Measured: Baseline, Day 2, Day 4, Week 1, Week 2, Week 3, and Week 4
Change in Self-Reported Energy Levels
Assessed via self-reported questionnaire measuring participants' perceptions of the product's effects on energy levels
Measured: Baseline, Day 2, Day 4, Week 1, Week 2, Week 3, and Week 4
Change in Self-Reported Focus
Assessed via self-reported questionnaire measuring participants' perceptions of the product's effects on focus
Measured: Baseline, Day 2, Day 4, Week 1, Week 2, Week 3, and Week 4
Change in Self-Reported Calmness
Assessed via self-reported questionnaire measuring participants' perceptions of the product's effects on calmness
Measured: Baseline, Day 2, Day 4, Week 1, Week 2, Week 3, and Week 4
Change in Self-Reported General Well-Being
Assessed via self-reported questionnaire measuring participants' perceptions of the product's effects on general well-being
Measured: Baseline, Day 2, Day 4, Week 1, Week 2, Week 3, and Week 4
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted4 Aug 2026
- Study start15 Aug 2025
- Primary completion15 Nov 2025
- Study completion15 Nov 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Sleep DisturbanceStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 24 participants (actual)
Sponsor and investigators
- Lead sponsor
- Life Harmony Energies, Inc.
- Sponsor type
- Industry (pharma, biotech, devices)
- Collaborators
- Citruslabs
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07746011
- Sponsor's protocol ID
- 20760
- Other IDs
- legacy-20760
- Status last verified
- Aug 2026
- First submitted
- 28 Jul 2026
- Last updated
- 4 Aug 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 4 Aug 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Clinical Trial to Evaluate the Effects of EMF Protection Devices on Sleep and Energy Levels
- ClinicalTrials.gov ID
- NCT07746011
- Acronym / sponsor ID
- 20760
- Conditions
- Sleep Disturbance, Insomnia, Fatigue, Electromagnetic Field Exposure
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 24 participants (actual)
- Lead sponsor
- Life Harmony Energies, Inc.Industry (pharma, biotech, devices)
- Collaborators
- Citruslabs
- Study start
- 15 Aug 2025 (actual)
- Primary completion
- 15 Nov 2025 (actual)
- Study completion
- 15 Nov 2025 (actual)
- First posted
- 4 Aug 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study evaluates the effects of a selection of EMF protection devices (Home Harmonizers, Better ZZZs, iCell Chip, Car Harmonizer, Laptop Chip, XL Band, and Device Chips) on sleep quality, sleep quantity, and energy levels in adults aged 30-60 who currently experience sleep difficulties. The trial is a single-arm, unblinded, virtual study conducted over 4 weeks and 4 days (including a 4-day calibration period).
Twenty-four participants will use all test products daily and complete self-reported questionnaires at Baseline, Day 2, Day 4, Week 1, Week 2, Week 3, and Week 4. Objective sleep data will be collected via an Oura Generation 3 ring worn throughout the study. Secondary outcomes include participants' perceptions of effects on sleep, energy, focus, and general well-being.
Study design
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| EMF Protection Devices | Experimental | Device: EMF Protection |
Who may qualify
- Ages
- 30 to 60 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult
Key inclusion criteria (15 listed)
- Be male or female
- Be aged 30-60
- Anyone currently experiencing issues regarding any of the following: sleeping, falling asleep, staying asleep, or failing to feel refreshed after sleep
- Must have all of the following items: bed with a foam or spring mattress, a car with a single cigarette lighter, iPhone 12, 13, 14, 15, or 16, laptop, and Wi-Fi router
- Must have at least two of the following: Wi-Fi extender, smart TV, personal computer, ceiling fan in the bedroom, air purifier
Key exclusion criteria (10 listed)
- Anyone with pre-existing chronic conditions that would prevent participants from adhering to the protocol, such as cancer, auto-immune conditions, mental health disorders, history of serious illness in the last three months, history of substance abuse, or planned surgery during the study period
- Sleeps on any of the following beds: adjustable beds, beds equipped with grounding mats, or any bed that connects to an electrical outlet
- Anyone with a sleep-related condition or disorder
- Anyone who is pregnant, breastfeeding, or trying to conceive (or who will be at any point during the study period)
- Anyone who drinks heavily (i.e., 8 or more alcoholic drinks per week for women or 15 or more alcoholic drinks per week for men)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| EMF ProtectionAll participants receive and use all test products simultaneously: 2 Home Harmonizers, 1 Better ZZZs pad (placed under mattress), 1 iCell Chip (for iPhone 12-16), 1 Car Harmonizer (inserted into car cigarette lighter), 1 Laptop Chip, 1 XL Band (worn on wrist during waking hours), and 8 Device Chips (placed on household EMF-emitting devices). | Device | EMF Protection Devices |
Primary outcome
Change in objective sleep quality
Time frame: Baseline, Day 2, Day 4, Week 1, Week 2, Week 3, and Week 4
Assessed using Oura Generation 3 ring sleep metrics. Change from baseline will be evaluated at each subsequent assessment.
5 secondary outcomes
Change in Self-Reported Sleep
Time frame: Baseline, Day 2, Day 4, Week 1, Week 2, Week 3, and Week 4
Change in Self-Reported Energy Levels
Time frame: Baseline, Day 2, Day 4, Week 1, Week 2, Week 3, and Week 4
Change in Self-Reported Focus
Time frame: Baseline, Day 2, Day 4, Week 1, Week 2, Week 3, and Week 4
Change in Self-Reported Calmness
Time frame: Baseline, Day 2, Day 4, Week 1, Week 2, Week 3, and Week 4
Change in Self-Reported General Well-Being
Time frame: Baseline, Day 2, Day 4, Week 1, Week 2, Week 3, and Week 4
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 4 Aug 2026.
Related trials for Sleep Disturbance
Recruiting
Addressing Nocturia in Older Women Utilizing Behavioral Sleep Intervention and Brief Mindfulness
Nocturia, Insomnia
Recruiting
Investigation of the Effects of Sleep Deprivation on Itch and Pain Sensitivity
Histamine, Cowhage
RecruitingObservational study
Locus Coeruleus and CCHS (Congenital Central Hypoventilation Syndrome)
Ondine Syndrome (Congenital Central Hypoventilation Syndrome)
Not yet recruiting
A Transdiagnostic Sleep Health Intervention for Veterans With PTSD
Stress Disorders, Post-Traumatic, Sleep Initiation and Maintenance Disorders
RecruitingObservational study
Development and Validation of a Multimodal Deep Learning Model Using Peripheral Oxygen Saturation and Ballistocardiography Signals for Predicting Apnea-Hypopnea Index in Obstructive Sleep Apnea
Obstructive Sleep Apnea
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing EMF Protection in people with Sleep Disturbance and Insomnia, run by Life Harmony Energies, Inc. at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 15 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 4 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change in objective sleep quality (time frame: Baseline, Day 2, Day 4, Week 1, Week 2, Week 3, and Week 4). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Aug 2026.